That statement is missing a lot of context, and as written it’s very misleading.
The European Medicines Agency does not issue blanket “immediate recalls of drugs” for broad categories based on a claim like “brain damage after a single dose.” What it does do is evaluate specific medicines and, if needed, recommend actions such as:
- updating warnings
- restricting use
- suspending a specific product
- or, in rare cases, withdrawing a specific medicine from the market
But those actions are always tied to a particular drug, formulation, and risk profile, not a general statement about “drugs” in plural.
Also, “brain damage after a single dose” is not a standard EMA-wide finding. That kind of wording usually comes from:
- social media misinterpretations
- news headlines stripped of context
- or confusion between different medications and different risks (for example, long-term neurological risks vs acute overdose situations)
If you can share the name of the drug or the article you saw, I can break down what the EMA actually said and whether there’s any real safety issue behind it.
